471 related articles for article (PubMed ID: 30947260)
21. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.
Masson L; Mlisana K; Little F; Werner L; Mkhize NN; Ronacher K; Gamieldien H; Williamson C; Mckinnon LR; Walzl G; Abdool Karim Q; Abdool Karim SS; Passmore JA
Sex Transm Infect; 2014 Dec; 90(8):580-7. PubMed ID: 25107710
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterisation of vaginal lactobacilli from South African women.
Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H
BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177
[TBL] [Abstract][Full Text] [Related]
23. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells.
Masson L; Salkinder AL; Olivier AJ; McKinnon LR; Gamieldien H; Mlisana K; Scriba TJ; Lewis DA; Little F; Jaspan HB; Ronacher K; Denny L; Abdool Karim SS; Passmore JA
Immunology; 2015 Dec; 146(4):557-67. PubMed ID: 26302175
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
[TBL] [Abstract][Full Text] [Related]
25. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
26. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
27. Genital inflammation and the risk of HIV acquisition in women.
Masson L; Passmore JA; Liebenberg LJ; Werner L; Baxter C; Arnold KB; Williamson C; Little F; Mansoor LE; Naranbhai V; Lauffenburger DA; Ronacher K; Walzl G; Garrett NJ; Williams BL; Couto-Rodriguez M; Hornig M; Lipkin WI; Grobler A; Abdool Karim Q; Abdool Karim SS
Clin Infect Dis; 2015 Jul; 61(2):260-9. PubMed ID: 25900168
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
[TBL] [Abstract][Full Text] [Related]
29. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
30. Cervicovaginal cytokines, sialidase activity and bacterial load in reproductive-aged women with intermediate vaginal flora.
Santos-Greatti MMV; da Silva MG; Ferreira CST; Marconi C
J Reprod Immunol; 2016 Nov; 118():36-41. PubMed ID: 27620141
[TBL] [Abstract][Full Text] [Related]
31. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
[TBL] [Abstract][Full Text] [Related]
32. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
33. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
[TBL] [Abstract][Full Text] [Related]
34. Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa.
Abbai NS; Reddy T; Ramjee G
Int J STD AIDS; 2016 Dec; 27(14):1283-1288. PubMed ID: 26538552
[TBL] [Abstract][Full Text] [Related]
35. The Cervicovaginal Microbiota in Women Notified for Chlamydia trachomatis Infection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands.
van der Veer C; Bruisten SM; van der Helm JJ; de Vries HJ; van Houdt R
Clin Infect Dis; 2017 Jan; 64(1):24-31. PubMed ID: 27567124
[TBL] [Abstract][Full Text] [Related]
36. Deep sequencing of the vaginal microbiota of women with HIV.
Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
[TBL] [Abstract][Full Text] [Related]
37. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
38. Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection.
Balle C; Lennard K; Dabee S; Barnabas SL; Jaumdally SZ; Gasper MA; Maseko V; Mbulawa ZZA; Williamson AL; Bekker LG; Lewis DA; Passmore JS; Jaspan HB
Sci Rep; 2018 Jul; 8(1):11109. PubMed ID: 30038262
[TBL] [Abstract][Full Text] [Related]
39. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.
Masson L; Arnold KB; Little F; Mlisana K; Lewis DA; Mkhize N; Gamieldien H; Ngcapu S; Johnson L; Lauffenburger DA; Abdool Karim Q; Abdool Karim SS; Passmore JA
Sex Transm Infect; 2016 May; 92(3):186-93. PubMed ID: 26511781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
